APA (7th ed.) Citation

Gottlieb, A. B., Burge, R., Malatestinic, W. N., Zhu, B., Zhao, Y., McCormack, J., . . . Merola, J. F. (2023). Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program. Dermatology & Therapy, 13(8), 1831. https://doi.org/10.1007/s13555-023-00969-1

Chicago Style (17th ed.) Citation

Gottlieb, Alice B., Russel Burge, William N. Malatestinic, Baojin Zhu, Yunyang Zhao, Julie McCormack, Miriam Kimel, and Joseph F. Merola. "Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program." Dermatology & Therapy 13, no. 8 (2023): 1831. https://doi.org/10.1007/s13555-023-00969-1.

MLA (9th ed.) Citation

Gottlieb, Alice B., et al. "Ixekizumab Real-World Effectiveness at 24 Weeks in Patients with Psoriasis: Data from the United States Taltz Customer Support Program." Dermatology & Therapy, vol. 13, no. 8, 2023, p. 1831, https://doi.org/10.1007/s13555-023-00969-1.